Evidence map›Paper›PMID 36406650›Full record

ArticleJGH open : an open access journal of gastroenterology and hepatology2022

Simple algorithm to narrow down the candidates to receive echocardiography in patients with chronic liver disease for suspected pulmonary hypertension.

Koji Yamashita, Masayuki Kurosaki, Hiroyuki Nakanishi, Yuki Tanaka, Shun Ishido, Kento Inada, Sakura Kirino, Yuka Hayakawa, Hiroaki Matsumoto, Tsubasa Nobusawa and 14 more

Open access · goldAbstract read
In one paragraph

Article in JGH open : an open access journal of gastroenterology and hepatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 2 institutions in 1 country.

Koji YamashitaDepartment of Gastroenterology and Hepatology Musashino Red Cross Hospital Tokyo Japan.ORCID https://orcid.org/0000-0002-8356-130X
Masayuki KurosakiDepartment of Gastroenterology and Hepatology Musashino Red Cross Hospital Tokyo Japan.ORCID https://orcid.org/0000-0001-7016-8931
Hiroyuki NakanishiDepartment of Gastroenterology and Hepatology Musashino Red Cross Hospital Tokyo Japan.
Yuki TanakaDepartment of Gastroenterology and Hepatology Musashino Red Cross Hospital Tokyo Japan.
Shun IshidoDepartment of Gastroenterology and Hepatology Musashino Red Cross Hospital Tokyo Japan.
Kento InadaDepartment of Gastroenterology and Hepatology Musashino Red Cross Hospital Tokyo Japan.ORCID https://orcid.org/0000-0002-6367-6396
Sakura KirinoDepartment of Gastroenterology and Hepatology Musashino Red Cross Hospital Tokyo Japan.
Yuka HayakawaDepartment of Gastroenterology and Hepatology Musashino Red Cross Hospital Tokyo Japan.
Hiroaki MatsumotoDepartment of Gastroenterology and Hepatology Musashino Red Cross Hospital Tokyo Japan.
Tsubasa NobusawaDepartment of Gastroenterology and Hepatology Musashino Red Cross Hospital Tokyo Japan.
Tatsuya KakegawaDepartment of Gastroenterology and Hepatology Musashino Red Cross Hospital Tokyo Japan.
Mayu HiguchiDepartment of Gastroenterology and Hepatology Musashino Red Cross Hospital Tokyo Japan.
Kenta TakauraDepartment of Gastroenterology and Hepatology Musashino Red Cross Hospital Tokyo Japan.
Shohei TanakaDepartment of Gastroenterology and Hepatology Musashino Red Cross Hospital Tokyo Japan.
Chiaki MaeyashikiDepartment of Gastroenterology and Hepatology Musashino Red Cross Hospital Tokyo Japan.
Shun KanekoDepartment of Gastroenterology and Hepatology Musashino Red Cross Hospital Tokyo Japan.ORCID https://orcid.org/0000-0003-2660-6580
Nobuharu TamakiDepartment of Gastroenterology and Hepatology Musashino Red Cross Hospital Tokyo Japan.ORCID https://orcid.org/0000-0003-4634-6616
Yutaka YasuiDepartment of Gastroenterology and Hepatology Musashino Red Cross Hospital Tokyo Japan.ORCID https://orcid.org/0000-0002-6117-4990
Kaoru TsuchiyaDepartment of Gastroenterology and Hepatology Musashino Red Cross Hospital Tokyo Japan.
Yuka TakahashiDepartment of Gastroenterology and Hepatology Musashino Red Cross Hospital Tokyo Japan.
Ryoichi MiyazakiDepartment of Cardiology Musashino Red Cross Hospital Tokyo Japan.
Takashi AshikagaDepartment of Cardiology Musashino Red Cross Hospital Tokyo Japan.
Nobuyuki EnomotoFirst Department of Internal Medicine, Faculty of Medicine University of Yamanashi Yamanashi Japan.
Namiki IzumiDepartment of Gastroenterology and Hepatology Musashino Red Cross Hospital Tokyo Japan.
Musashino Red Cross Hospital · JPUniversity of Yamanashi · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aims: Portopulmonary hypertension (PoPH) is a subtype of pulmonary arterial hypertension related to portal hypertension. The definitive diagnosis of PoPH is made by invasive right heart catheterization. Alternatively, pulmonary arterial hypertension may be recognized noninvasively from the tricuspid regurgitant pressure gradient (TRPG), measured by echocardiography. In this study, we aimed to establish a simple algorithm to identify chronic liver disease patients with a high TRPG value in order to narrow down the candidates to receive echocardiography. Methods and Results: TRPG was measured by echocardiography in 152 patients with chronic liver disease. Factors predictive of TRPG >30 mmHg were investigated. There were 28 (18%) cases with TRPG >30 mmHg. Independent factors associated with a high TRPG were the presence of shortness of breath, high serum brain natriuretic peptide (BNP), and low serum albumin. Child-Pugh class or the presence of ascites, varices, or encephalopathy was not associated with TRPG. There was a correlation between the serum BNP and TRPG, and the optimal cutoff value of BNP by the Youden index was 122 pg/mL, and by 100% sensitivity was 50 pg/mL. A combination of these factors identified patients with a high probability of TRPG >30 mmHg ( Conclusions: A simple algorithm using the presence of shortness of breath, serum BNP, and albumin levels can narrow down the candidates to receive echocardiography.

Indexed as

hepatologyportal hypertensionscreening and diagnosis

Identifiers

PMID36406650
PMCPMC9667407
OpenAlexW4295979608

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.